Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy

Brain

Volumn 108, Issue 4, 1985, Pages 861-880

  Dyck, Peter James ^a   Karnes, Jeannine L ^a   Daube, Jasper ^a   O'brien, Peter ^a   Service, F John ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIAGNOSIS; ENDOCRINE SYSTEM; HISTOLOGY; HUMAN; NERVE CONDUCTION; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NORMAL HUMAN; NORMAL VALUE; PERIPHERAL NERVOUS SYSTEM; POLYNEUROPATHY; PRIORITY JOURNAL; SKIN SENSATION; STAGING;

ADOLESCENT; ADULT; AGED; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURONS; NEURAL CONDUCTION; SENSATION; SURAL NERVE;

EID: 0022401992     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/108.4.861     Document Type: Article

References (75)

1. Ashton N (1963) Studies of the retinal capillaries in relation to diabetic and other retinopathies. British Journal of Ophthalmology, 47, 521-538.
2. Beahrs O H, Myers M H, editors (1983) Manual for Staging of Cancer. Second edition. Philadelphia: Lippincott.
3. Behse F, Buchthal F, Carlsen F (1977) Nerve biopsy and conduction studies in diabetic neuropathy. Journal of Neurology, Neurosurgery and Psychiatry, 40, 1072-1082.
4. Bischoff A (1963) Die Diabetische Neuropathic. Stuttgart: Thieme.
5. Bouchard M (1884) Loss of the knee-phenomenon in diabetes. British Medical Journal, 1, 237-239.
6. Brismar T, Sima A A F (1981) Changes in nodal function in nerve fibres of the spontaneously diabetic BB-Wistar rat: potential clamp analysis. Acta Physiologica Scandinavica, 113, 499-506.
7. Brown M J, Martin J R, Asbury A K (1976) Painful diabetic neuropathy: a morphometric study. Archives of Neurology, Chicago, 33, 164-171.
8. Brown M J, Dyck P J, McClearn G E, Sima A A F, Powell H C, Porte D (1982) Central and peripheral nervous system complications. Diabetes, 31, Supplement 1, 65-70.
9. Brown M J, Asbury A K (1984) Diabetic neuropathy. Annals of Neurology, 15, 2-12.
10. Buchthal F, Rosenfalck A (1966) Evoked action potentials and conduction velocity in human sensory nerves. Brain Research, Amsterdam, 3, 1-122.
11. Buchthal F, Rosenfalck A (1971) Sensory potentials in polyneuropathy. Brain, 94, 241-262.
12. Chopra J S, Hurwitz L J, Montgomery DAD (1969) The pathogenesis of sural nerve changes in diabetes mellitus. Brain, 92, 391-418.
13. Cune M J, Haskell C M (1980) Cancer Chemotherapy. Third edition. Philadelphia and London: Saunders.
14. Culp W J, Ochoa J, editors (1982) Abnormal Nerves and Muscles as Impulse Generators. New York: Oxford University Press.
15. Danta G (1976) Serial nerve conduction studies in patients with maturity onset diabetes mellitus. Proceedings of the Australian Association of Neurologists, 13, 123-126.
16. Davis M D, MacCormick A J A, Harris W A C, Haug G A, Long J W, Magli Y L, Harris J A (1976) Diabetic retinopathy prevalence and importance. Acta Ophthalmologica, 1, 165-173.
17. Devor M, Janig W (1981) Activation of myelinated afferents ending in a neuroma by stimulation of the sympathetic supply in the rat. Neuroscience Letters, 24, 43-47.
18. Diabetic Retinopathy Study Research Group (1981) Diabetic Retinopathy Study. Investigative Ophthalmology and Visual Science, 21, 149-226.
19. Downie A W, Newell D J (1961) Sensory nerve conduction in patients with diabetes mellitus and controls. Neurology, Minneapolis, 11, 876-882.
20. Dyck P J, Lambert E H, Nichols P C (1971) Quantitative measurement of sensation related to compound action potential and number and sizes of myelinated and unmyelinated fibers of sural nerve in health, Friedreich’s ataxia, hereditary sensory neuropathy, and tabes dorsalis. In: Handbook of Electroencephalography and Clinical Neurophysiology, Volume 9. Edited by A. Rbmond. Amsterdam: Elsevier, pp. 83-118.
21. Dyck P J, Lambert E H, O’Brien PC (1976) Pain in peripheral neuropathy related to rate and kind of fiber degeneration. Neurology, Minneapolis, 26, 466-471.
22. Dyck P J, Zimmerman I R, O’Brien P C, Ness A, Caskey P E, Karnes J, Bushek W (1978) Introduction of automated systems to evaluate touch-pressure, vibration and thermal cutaneous sensation in man. Annals of Neurology, 4, 502-510.
23. Dyck P J, Sherman W R, Hallcher L M, Service F J, O’Brien P C, Grina L A, Palumbo P J, Swanson C J (1980) Human diabetic endoneurial sorbital, fructose and myoinositol related to sural nerve morphometry. Annals of Neurology, 8, 590-596.
24. Dyck P J, Lambert E H, Windebank A J, Lais A A, Sparks M F, Karnes J, Sherman W R, Hallcher L M, Low PA, Service F J (1981) Acute hyperosmolar hyperglycemia causes axonal shrinkage and reduced nerve conduction velocity. Experimental Neurology, 71, 507-514.
25. Dyck P J, Pineda A, Swanson C, Low P, Windebank A, Daube J (1982a) The Mayo Clinic experience with plasma exchange in chronic inflammatory-demyelinating polyneuropathy (CIDP). Progress in Clinical and Biological Research, 106, 197-204.
26. Dyck P J, O’Brien P C, Oviatt K F, Dinapoli R P, Daube J R, Bartleson J D, Mokri B, Swift T, Low P A, Windebank A J (1982) Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Annals of Neurology, 11, 136-141.
27. Dyck P J, Karnes J, O’Brien P C, Zimmerman I R (1984a) Detection thresholds of cutaneous sensation in humans. In: Peripheral Neuropathy. Second edition. Edited by P. J. Dyck, P. K. Thomas, E. H. Lambert and R. Bunge. Philadelphia: Saunders, pp. 1103-1138.
28. Dyck P J, Karnes J, Lais A, Lofgren E P, Stevens J C (19846) Pathologic alterations of the peripheral nervous system of humans. In: Peripheral Neuropathy. Second edition. Edited by P. J. Dyck, P. K. Thomas, E. H. Lambert and R. Bunge. Philadelphia: Saunders, pp. 760-870.
29. Dyck P J, Hansen S, Karnes J, O’Brien P C, Yasuda H, Windebank A, Zimmerman B (1985) Capillary number and percentage closed in human diabetic nerve. Proceedings of the National Academy of Science, 82, 2513-2517.
30. Eliasson S G (1971) Disorders of the nervous system in diabetes. Medical Clinics of North America, 55, 1001-1006.
31. Fog T (1965) A scoring system for neurological impairment in multiple sclerosis. Acta Neurologica Scandinavica, 41, Supplement 13, Part 2, 551-555.
32. Gehan E A (1982) Progress of therapy in acute leukemia 1948-1981: randomized versus non- randomized clinical trials. Controlled Clinical Trials, 3, 199-207.
33. Giluatt R W (1965) Clinical aspects of diabetic neuropathy. In: Biochemical Aspects of Neurological Disorders. Second series. Edited by J. N. Cumings and M. Kremer. Oxford: Blackwell, pp. 117-142.
34. Giluatt R W, Willison R G (1962) Peripheral nerve conduction in diabetic neuropathy. Journal of Neurology, Neurosurgery and Psychiatry, 25, 11-18.
35. Greenbaum D (1964) Observations on the homogeneous nature and pathogenesis of diabetic neuropathy. Brain, 87, 215-232.
36. Greene D A, De Jesus P V, Winegrad A I (1975) Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. Journal of Clinical Investigation, 55, 1326-1336.
37. Greene D A, Lattimer S A (1983) Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. Journal of Clinical Investigation, 72, 1058-1063.
38. Gregersen G (1967) Diabetic neuropathy: influence of age, sex, metabolic control, and duration of diabetes on motor conduction velocity. Neurology, Minneapolis, 17, 972-980.
39. Harris M, Cahill G (and members of NIH Diabetes Data Group Workshop) (1978) A draft classification of diabetes mellitus and other categories of glucose tolerance. (Widely distributed for comments and suggestions.)
40. Hathaway S R, Meehl P E (1951) An Atlas for the Clinical Use of the MMPI. Minneapolis: University of Minnesota Press.
41. Hauser S L, Dawson D M, Lehrich J R, Beal M F, Kevy S V, Propper R D, Mills J A, Weiner H L (1983) Intensive immunosuppression in progressive multiple sclerosis: a randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. New England Journal of Medicine, 308, 173-180.
42. Hughes RAC, Kadlubowski M, Hufschmidt A (1981) Treatment of acute inflammatory polyneuropathy. Annals of Neurology, 9, Supplement, 125-133.
43. Jakobsen J (1976) Axonal dwindling in early experimental diabetes. II. A study of isolated nerve fibres. Diabetologia, 12, 547-553.
44. Jakobsen J (1979) Early and preventable changes of peripheral nerve structure and function in insulin- deficient diabetic rats. Journal of Neurology, Neurosurgery and Psychiatry, 42, 509-518.
45. Jakobsen J, Sidenius P (1980) Decreased axonal transport of structural proteins on streptozotocin diabetic rats. Journal of Clinical Investigation, 66, 292-297.
46. Karnes J, Robb R, O’Brien PC, Lambert E H, Dyck P J (1977) Computerized image recognition for morphometry of nerve attribute of shape of sampled transverse sections of myelinated fibers which best estimates their average diameter. Journal of the Neurological Sciences, 34, 43-51.
47. Kimura J, Yamada T, Stevland N P (1979) Distal slowing of motor nerve conduction velocity in diabetic polyneuropathy. Journal of the Neurological Sciences, 42, 291-302.
48. Kurtzke J F (1961) On the evaluation of disability in multiple sclerosis. Neurology, Minneapolis, 11, 686-694.
49. Lambert E H, Dyck P J (1984) Compound action potentials of sural nerve in vitro in peripheral neuropathy. In: Peripheral Neuropathy. Second edition. Edited by P. J. Dyck, P. K. Thomas, E. H. Lambert and R. Bunge. Philadelphia: Saunders, pp. 1030-1044.
50. LaMontagne A, Buchthal F (1970) Electrophysiological studies in diabetic neuropathy. Journal of Neurology, Neurosurgery and Psychiatry, 33, 442-452.
51. Lawrence D G, Locke S (1962) Motor nerve conduction velocity in diabetes. Archives of Neurology, Chicago, 7, 365-367.
52. Loh L, Nathan P W (1978) Painful peripheral states and sympathetic blocks. Journal of Neurology, Neurosurgery and Psychiatry, 41, 664-671.
53. Low P A, Tuck R R, Dyck P J, Schmelzer J D, Yao J K (1985) Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Proceedings of the National Academy of Science. In press.
54. McAlpine D, Compston N (1952) Some aspects of the natural history of disseminated sclerosis. Quarterly Journal of Medicine, 21, 135-167.
55. Mayer R F (1963) Nerve conduction studies in man. Neurology, Minneapolis, 13, 1021-1030.
56. Mulder D W, Lambert E H, Bastron J A, Sprague R G (1961) The neuropathies associated with diabetes mellitus: a clinical and electromyographic study of 103 unselected diabetic patients. Neurology, Minneapolis, 11, 275-284.
57. Nathan P W (1978) Painful legs and moving toes: evidence on the site of the lesion. Journal of Neurology, Neurosurgery and Psychiatry, 41, 934-939.
58. Nosl P (1973) Sensory nerve conduction in the upper limbs at various stages of diabetic neuropathy. Journal of Neurology, Neurosurgery and Psychiatry, 36, 786-796.
59. Palumbo P J, Elveback L R, Chu-Pin C, Connolly D C, Kurland L T (1976) Diabetes mellitus: incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota, 1945-1970. Diabetes, 25, 566-573.
60. Pedersen E (1965) A rating system for neurological impairment in multiple sclerosis. Acta Neurologica Scandinavica, 41, Supplement 13, Part 2, 557-558.
61. Pirart J (1965) Diabetic neuropathy: a metabolic or a vascular disease? Diabetes, 14, 1-9.
62. Rose A S, Kuzma J W, Kurtzke J F, Sibley W A, Tourtellotte W W (1968) Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs placebo in acute exacerbations. Neurology, Minneapolis, 18, Supplement.
63. Sharma A K, Thomas P K (1974) Peripheral nerve structure and function in experimental diabetes. Journal of the Neurological Sciences, 23, 1-15.
64. Sharma A K, Bajada S, Thomas P K (1981) Influence of streptozotocin-induced diabetes on myelinated nerve fibre maturation and on body growth in the rat. Acta Neuropathologica, Berlin, 53, 257-265.
65. Skillman T G, Johnson E W, Hamwi G J, Driskill H J (1961) Motor nerve conduction velocity in diabetes mellitus. Diabetes, 10, 46-51.
66. Steiness I (1957) Vibratory perception in diabetics: a bioesthesiometric study. Acta Medica Scandinavica, 158, 327-335.
67. Thomas P K (1974) The anatomical substratum of pain: evidence derived from morphometric studies on peripheral nerve. Canadian Journal of the Neurological Sciences 21, 92-97.
68. Thomas P K (1984) Animal models of metabolic neuropathies. In: Peripheral Neuropathy. Second edition. Edited by P. J. Dyck, P. K. Thomas, E. H. Lambert and R. Bunge. Philadelphia: Saunders, pp. 691-706.
69. Thomas P K, Euasson S G (1984) Diabetic neuropathy. In: Peripheral Neuropathy. Second edition. Edited by P. J. Dyck, P. K. Thomas, E. H. Lambert and R. Bunge. Philadelphia: Saunders, pp. 1773-1810.
70. TorebjOrk H E, Ochoa J L, McCann F V (1979) Paresthesiae: abnormal impulse generation in sensory nerve fibres in man. Acta Physiologica Scandinavica, 105, 518-520.
71. Tuck R R, Schmelzer J D, Low P A (1984) Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain, 107, 935-950.
72. Wall P D (1979) Changes in damaged nerve and their sensory consequences. Advances in Pain Research and Therapy, 3, 39-52.
73. West K M (1979) Standardization of definition, classification, and reporting in diabetes-related epidemiologic studies. Diabetes Care, 2, 65-76.
74. Zimmerman I R, Karnes J L, O’Brien P C, Dyck P J (1980) Imaging system for nerve and fiber tract morphometry: components, approaches, performance, and results. Journal of Neuropathology and Experimental Neurology, 39, 409-419.
75. Zimmermann M (1979) Peripheral and central nervous mechanisms of nociception, pain, and pain therapy: facts and hypotheses. Advances in Pain Research and Therapy, 3, 3-23.